From Trastuzumab to Trastuzumab Deruxtecan: Two Decades of Progress in HER2-Positive Advanced Breast Cancer, with a Focus on Central Nervous System Disease
Oncology Research · Monica Esteban-Garcia, Iseult M. Browne, Alicia F. C. Okines · 2026
- EnglishRead in your language
- CitedEvery fact sourced
- Ad-freeNo ads, no tracking
Quick facts
Questions
- Who wrote From Trastuzumab to Trastuzumab Deruxtecan: Two Decades of Progress in HER2-Positive Advanced Breast Cancer, with a Focus on Central Nervous System Disease?
- From Trastuzumab to Trastuzumab Deruxtecan: Two Decades of Progress in HER2-Positive Advanced Breast Cancer, with a Focus on Central Nervous System Disease was written by Monica Esteban-Garcia, Iseult M. Browne, Alicia F. C. Okines.
- When was From Trastuzumab to Trastuzumab Deruxtecan: Two Decades of Progress in HER2-Positive Advanced Breast Cancer, with a Focus on Central Nervous System Disease first published?
- From Trastuzumab to Trastuzumab Deruxtecan: Two Decades of Progress in HER2-Positive Advanced Breast Cancer, with a Focus on Central Nervous System Disease was first published in 2026.
Sources
Last updated · facts checked 4 November 2026
Cite this page
"From Trastuzumab to Trastuzumab Deruxtecan: Two Decades of Progress in HER2-Positive Advanced Breast Cancer, with a Focus on Central Nervous System Disease". DigiNepal. Last updated 4 November 2026. https://diginpl.com/books/paper-or-2026-090148. Retrieved 14 November 2026.
Open-access publication. Read it free at the publisher: https://doi.org/10.32604/or.2026.090148.